Induction of regulatory T cells: A role for probiotics and prebiotics to suppress autoimmunity

Autoimmunity Reviews

Volumn 15, Issue 4, 2016, Pages 379-392

  Dwivedi, Mitesh ^a   Kumar, Prasant ^a   Laddha, Naresh C ^b   Kemp, E Helen ^c  

^a UKA TARSADIA UNIVERSITY   (India)

^b Unipath   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Autoimmunity; CD8+ T cells; Immune regulation; Prebiotics; Probiotics; Regulatory T cells

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 109A; G PROTEIN COUPLED RECEPTOR 43; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; HISTONE DEACETYLASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; POLYSACCHARIDE; PREBIOTIC AGENT; PROBIOTIC AGENT; SHORT CHAIN FATTY ACID; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VITAMIN;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MICROBIAL COMMUNITY; MICROBIAL METABOLISM; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SKIN ALLERGY; T LYMPHOCYTE ACTIVATION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION;

AUTOIMMUNITY; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; PREBIOTICS; PROBIOTICS; T-LYMPHOCYTES, REGULATORY;

EID: 84959095501     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2016.01.002     Document Type: Review

References (198)

1. Tilg H., Moschen A.R. Food, immunity, and the microbiome. Gastroenterology 2015, 148:1107-1109.
2. Mazmanian S.K., Lee Y.K. Interplay between intestinal microbiota and host immune system. J Bacteriol Virol 2014, 44:1-9.
3. Fuller R. Probiotics in man and animals. J Appl Bacteriol 1989, 66:365-378.
4. de Vrese M., Schrezenmeir J. Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol 2008, 111:1-66.
5. Konieczna P., Akdis C.A., Quigley E.M., Shanahan F., O'Mahony L. Portrait of an immunoregulatory Bifidobacterium. Gut Microbes 2012, 3:261-266.
6. Geuking M.B., Köller Y., Rupp S., McCoy K.D. The interplay between the gut microbiota and the immune system. Gut Microbes 2014, 5:411-418.
7. Konieczna P., Groeger D., Ziegler M., Frei R., Ferstl R., Shanahan F., et al. Bifidobacterium infantis 35624 administration induces FoxP3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells. Gut 2012, 61:354-366.
8. Levings M., Sangregorio R., Roncarolo M. Human CD25(+)CD4(+) T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 2001, 193:1295-1302.
9. Round J.L., Mazmanian S.K. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009, 9:313-323.
10. Lee Y.K., Mazmanian S.K. Has the microbiota played a critical role in the evolution of the adaptive immune system?. Science 2010, 330:1768-1773.
11. Maloy K., Powrie F. Regulatory T-cells in the control of immune pathology. Nat Immunol 2001, 2:816-822.
12. Klarquist J., Denman C.J., Hernandez C., Wainwright D.A., Strickland F.M., Overbeck A., et al. Reduced skin homing by functional treg in vitiligo. Pigment Cell Melanoma Res 2010, 23:276-286.
13. Sakaguchi S. Naturally arising CD4(+) regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004, 22:531-562.
14. Antiga E., Kretz C., Klembt R., Massi D., Ruland V., Stumpf C., et al. Characterization of regulatory T cells in patients with dermatomyositis. J Autoimmun 2010, 35:342-350.
15. Miyara M., Amoura Z., Parizot C., Badoual C., Dorgham K., Trad S., et al. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 2005, 175:8392-8400.
16. Chi L.J., Wang H.B., Wang W.Z. Impairment of circulating CD4(+)CD25(+) regulatory T cells in patients with chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 2008, 13:54-63.
17. Dwivedi M., Kemp E.H., Laddha N.C., Mansuri M.S., Weetman A.P., Begum R. Regulatory T cells in vitiligo: implications for pathogenesis and therapeutics. Autoimmun Rev 2015, 14:49-56.
18. Weiner H.L., da Cunha A.P., Quintana F., Wu H. Oral tolerance. Immunol Rev 2011, 241:241-259.
19. + regulatory T-cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod 2004, 10:347-353.
20. high regulatory T-cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol 2005, 174:164-173.
21. + immunoregulatory T-cells is antigen nonspecific. J Immunol 2000, 164:183-190.
22. Thornton C., Harrington L., Mangan P., Gavrieli M., Murphy K. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006, 24:677-688.
23. + regulatory T cells requires CD69 expression. J Autoimmun 2014, 55:51-62.
24. + regulatory T cells allows for their purification from expansion cultures. Blood 2009, 113:5125-5133.
25. + treg free of contaminating effector cells. Blood 2009, 113:827-836.
26. + treg cell homeostasis in type I diabetes. Autoimmun Rev 2011, 11:104-111.
27. Xu W.D., Pan H.F., Ye D.Q., Xu Y. Targeting IRF4 in autoimmune diseases. Autoimmun Rev 2012, 11:918-924.
28. + T cells expressing the FoxP3 transcription factor. Immunity 2009, 30:899-911.
29. Huang C.T., Workman C.J., Flies D., Pan X., Marson A.L., Zhou G., et al. Role of LAG-3 in regulatory T cells. Immunity 2004, 21:503-513.
30. Seddiki N., Santner-Nanan B., Martinson J., Zaunders J., Sasson S., Landay A., et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006, 203:1693-1700.
31. Ronchetti S., Ricci E., Petrillo M.G., Cari L., Migliorati G., Nocentini G., et al. Glucocorticoid-induced tumour necrosis factor receptor-related protein: a key marker of functional regulatory T cells. J Immunol Res 2015, 2015:171520.
32. + regulatory T cells in the treatment of autoimmune diseases. Autoimmun Rev 2015, 14:117-126.
33. Liang B., Workman C., Lee J., Chew C., Dale B.M., Colonna L., et al. Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II. J Immunol 2008, 180:5916-5926.
34. Zhang Q., Qian F., Liu H., Zhou L., Huang M., Zhang X., et al. Expression of surface markers on peripheral CD4 + CD25high T-cells in patients with atopic asthma: role of inhaled corticosteroid. Chin Med J (Engl) 2008, 121:205-212.
35. Afzali B., Lombardi G., Lechler R., Lord G. The role of T helper 17 (Th17) and regulatory tcells (treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 2007, 148:32-46.
36. + regulatory T-cells in peripheral blood of patients with NSCLC. Cancer Biother Radiopharm 2009, 24:357-367.
37. Dejaco C., Duftner C., Grubeck-Loebenstein B., Schermer M. Imbalance of regulatory T cells in human autoimmune diseases. Immunol 2006, 117:289-300.
38. Miyara M., Sakaguchi S. Natural regulatory T cells: mechanisms of suppression. Trends Mol Med 2007, 13:108-116.
39. + regulatory T cells. J Leukoc Biol 2006, 80:458-470.
40. + treg immune regulation in the adult: from experiments to models. Front Immunol 2013, 4:378.
41. high regulatory T cell population in peripheral blood. Rheumatology (Oxford) 2006, 45:1210-1217.
42. + T cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol 2004, 59:198-202.
43. Hu S., Xiao W., Kong F., Ke D., Qin R., Su M. Regulatory T cells and their molecular markers in peripheral blood of the patients with systemic lupus erythematosus. J Huazhong Univ Sci Technolog Med Sci 2008, 28:549-552.
44. Glick A.B., Wodzinski A., Fu P., Levine A.D., Wald D.N. Impairment of regulatory T-cell function in autoimmune thyroid disease. Thyroid 2013, 23:871-878.
45. + regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients. Clin Exp Immunol 2007, 147:412-418.
46. Frisullo G., Nociti V., Iorio R., Patanella A.K., Caggiula M., Marti A., et al. Regulatory T cells fail to suppress CD4T + -bet + T cells in relapsing multiple sclerosis patients. Immunology 2009, 127:418-428.
47. + regulatory T cells in patients with immune thrombocytopenic purpura. Iran J Allergy Asthma Immunol 2014, 13:85-92.
48. + ratio correlate with disease onset and progression in patients with generalized vitiligo. Pigment Cell Melanoma Res 2013, 26:586-591.
49. + cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo. PLoS One 2012, 7.
50. Ben Ahmed M., Zaraa I., Rekik R., Elbeldi-Ferchiou A., Kourda N., Belhadj Hmida N., et al. Functional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo. Pigment Cell Melanoma Res 2012, 25:99-109.
51. Quaglino P., Ponti R., Novelli M., Savoia P., Fava P., Papini M., et al. Flow cytometric analyses of circulating regulatory T cells in patients with dermatitis herpetiformis and other immune mediated dermatoses. G Ital Dermatol Venereol 2013, 148:197-201.
52. Grant C.R., Liberal R., Mieli-Vergani G., Vergani D., Longhi M.S. Regulatory T-cells in autoimmune diseases: challenges, controversies and-yet-unanswered questions. Autoimmun Rev 2015, 14:105-116.
53. Buckner J.H. Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nat Rev Immunol 2010, 10:849-859.
54. Matsuzaki T., Takagi A., Ikemura H., Matsuguchi T., Yokokura T. Intestinal microflora: probiotics and autoimmunity. J Nutr 2007, 137:798S-802S.
55. Kubota A., He F., Kawase M., Harata G., Hiramatsu M., Lino H. Diversity of intestinal bifidobacteria in patients with Japanese cedar pollinosis and possible influence of probiotic intervention. Curr Microbiol 2011, 62:71-77.
56. Metchnikoff E. The prolongation of life: optimistic studies 1907, G. P. Putnam & Sons, London.
57. Food and Agriculture Organization, World Health Organization Report of joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. FAO/WHO Report 2001, 10-11. World Health Organization.
58. Vighi G., Marcucci F., Sensi L., Di Cara G., Frati F. Allergy and the gastrointestinal system. Clin Exp Immunol 2008, 153:3-6.
59. Rautava S., Isolauri E. The development of gut immune responses and gut microbiota: effects of probiotics in prevention and treatment of allergic disease. Curr Issues Intest Microbiol 2002, 3:15-22.
60. Heijtz R.D., Wang S., Anuar F., Qian Y., Bjorkholm B., Samuelsson A., et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A 2011, 108:3047-3052.
61. Vijay-Kumar M., Aitken J.D., Carvalho F.A., Cullender T.C., Mwangi S., Srinivasan S., et al. Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5. Science 2010, 328:228-231.
62. Maslowski K.M., Vieira A.T., Ng A., Kranich J., Sierro F., Yu D., et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009, 461:1282-1286.
63. Hooper L.V., Macpherson A.J. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 2010, 10:159-169.
64. Topping D.L., Clifton P.M. Short chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 2001, 81:1031-1064.
65. Kau A.L., Ahern P.P., Griffin N.W., Goodman A.L., Gordon J.I. Human nutrition, the gut microbiome and the immune system. Nature 2011, 474:327-336.
66. Atarashi K., Tanoue T., Shima T., Imaoka A., Kuwahara T., Momose Y., et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011, 331:337-341.
67. Hill D.A., Artis D. Intestinal bacteria and the regulation of immune cell homeostasis. Annu Rev Immunol 2010, 28:623-667.
68. Macpherson A.J., Harris N.L. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 2004, 4:478-485.
69. Uronis J.M., Muhlbauer M., Herfarth H.H., Rubinas T.C., Jones G.S., Jobin C. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS One 2009, 4.
70. Min Y.W., Rhee P.L. The role of microbiota on the gut immunology. Clin Ther 2015, 37:968-975.
71. Wu H.J., Wu E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes 2012, 3:4-14.
72. Schley P.D., Field C.J. The immune-enhancing effects of dietary fibres and prebiotics. Brit J Nutr 2002, 87:S221-S230.
73. Kolida S., Tuohy K., Gibson G.R. Prebiotic effects of inulin and oligofructose. Brit J Nutr 2002, 87:S193-S197.
74. Vinolo M.A., Rodrigues H.G., Nachbar R.T., Curi R. Regulation of inflammation by short chain fatty acids. Nutrients 2011, 3:858-876.
75. Park J.S., Lee E.J., Lee J.C., Kim W.K., Kim H.S. Anti-inflammatory effects of short chain fatty acids in IFN-γ-stimulated RAW 264.7 murine macrophage cells: involvement of NF-kB and ERK signaling pathways. Int Immunopharmacol 2007, 7:70-77.
76. Chakravortty D., Koide N., Kato Y., Sugiyama T., Mu M.M., Yoshida T., et al. The inhibitory action of butyrate on lipopolysaccharide-induced nitric oxide production in RAW 264.7 murine macrophage cells. J Endotoxin Res 2000, 6:243-247.
77. Menzel T., Luhrs H., Zirlik S., Schauber J., Kudlich T., Gerke T., et al. Butyrate inhibits leukocyte adhesion to endothelial cells via modulation of VCAM-1. Inflamm Bowel Dis 2004, 10:122-128.
78. Bohmig G.A., Krieger P.M., Saemann M.D., Wenhardt C., Pohanka E., Zlabinger G.J. n-Butyrate downregulates the stimulatory function of peripheral blood-derived antigen-presenting cells: A potential mechanism for modulating T-cell responses by short-chain fatty acids. Immunology 1997, 92:234-243.
79. Huda-Faujan N., Abdulamir A.S., Fatimah A.B., Anas O.M., Shuhaimi M., Yazid A.M., et al. The impact of the level of the intestinal short chain fatty acids in inflammatory bowel disease patients versus healthy subjects. Open Biochem J 2010, 4:53-58.
80. Vernia P., Caprilli R., Latella G., Barbetti F., Magliocca F.M., Cittadini M. Fecal lactate and ulcerative colitis. Gastroenterology 1988, 95:1564-1568.
81. McIntyre A., Gibson P.R., Young G.P. Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. Gut 1993, 34:386-391.
82. Cox M.A., Jackson J., Stanton M., Rojas-Triana A., Bober L., Laverty M., et al. Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokines. World J Gastroenterol 2009, 15:5549-5557.
83. Wiemer A.J., Hegde S., Gumperz J.E., Huttenlocher A. A live imaging cell motility screen identifies prostaglandin E2 as a T cell stop signal antagonist. J Immunol 2011, 187:3663-3670. (Baltimore, Md.: 1950).
84. Tedelind S., Westberg F., Kjerrulf M., Vidal A. Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J Gastroenterol 2007, 13:2826-2832.
85. Vinolo M.A., Rodrigues H.G., Hatanaka E., Sato F.T., Sampaio S.C., Curi R. Suppressive effect of short chain fatty acids on production of proinflammatory mediators by neutrophils. J Nutr Biochem 2011, 22:849-855.
86. Bringiotti R., Ierardi E., Lovero R., Losurdo G., Di Leo A., Principi M. Intestinal microbiota: the explosive mixture at the origin of inflammatory bowel disease?. World J Gastrointest Pathophysiol 2014, 5:550-559.
87. Moro G., Arslanoglu S., Stahl B., Jelinek J., Wahn U., Boehm G. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child 2006, 91:814-819.
88. Bassaganya-Riera J., DiGuardo M., Viladomiu M., deHorna A., Sanchez S., Einerhand A.W.C., et al. Soluble fibers and resistant starch ameliorate disease activity in interleukin-10-deficient mice with inflammatory bowel disease. J Nutr 2011, 141:1318-1325.
89. Vulevic J., Drakoularakou A., Yaqoob P., Tzortzis G., Gibson R.G. Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am J Clin Nutr 2008, 88:1438-1446.
90. Smits H.H., Engering A., van der Kleij D., de Jong E.C., Schipper K., van Capel T.M., et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 2005, 115:1260-1267.
91. Konstantinov S.R., Smidt H., de Vos W.M., Bruijns S.C., Singh S.K., Valence F., et al. S layer protein a of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc Natl Acad Sci U S A 2008, 105:19474-19479.
92. Christensen H.R., Frokiaer H., Pestka J.J. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 2002, 168:171-178.
93. Di Giacinto C., Marinaro M., Sanchez M., Strober W., Boirivant M. Probiotics ameliorate recurrent Th-1 mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-β- bearing regulatory cells. J Immunol 2005, 174:3237-3246.
94. Niers L.E., Hoekstra M.O., Timmerman H.M., van Uden N.O., de Graaf P.M., Smits H.H., et al. Selection of probiotic bacteria for prevention of allergic diseases: immunomodulation of neonatal dendritic cells. Clin Exp Immunol 2007, 149:344-352.
95. Niers L.E., Timmerman H.M., Rijkers G.T., van Bleek G.M., van Uden N.O., Knol E.F., et al. Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clin Exp Allergy 2005, 35:1481-1489.
96. Hart A.L., Lammers K., Brigidi P., Vitali B., Rizzello F., Gionchetti P., et al. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 2004, 53:1602-1609.
97. + T cells via modulation of dendritic cell function. Am J Clin Nutr 2004, 80:1618-1625.
98. Drakes M., Blanchard T., Czinn S. Bacterial probiotic modulation of dendritic cells. Infect Immun 2004, 72:3299-3309.
99. Rigby R.J., Knight S.C., Kamm M.A., Stagg A.J. Production of interleukin (IL)-10 and IL-12 by murine colonic dendritic cells in response to microbial stimuli. Clin Exp Immunol 2005, 139:245-256.
100. + T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci U S A 2010, 107:2159-2164.
101. + regulatory T-cells. Int Immunol 2004, 16:1643-1656.
102. Joetham A., Takeda K., Taube C., Miyahara N., Matsubara S., Koya T., et al. Naturally occurring lung CD4(+)CD25(+) T cell regulation of airway allergic responses depends on IL-10 induction of TGF-β. J Immunol 2007, 178:1433-1442.
103. - precursors. J Immunol 2002, 169:4183-4189.
104. - precursors. Am J Transplant 2004, 4:1614-1627.
105. - T cells through FoxP3 induction and down-regulation of Smad7. J Immunol 2004, 172:5149-5153.
106. + regulatory T cells in vivo requires B7 costimulation, but not the thymus. J Exp Med 2005, 201:127-137.
107. + regulatory T cells. J Mol Cell Biol 2010, 2:30-36.
108. + tregs: limiting collateral damage. J Clin Invest 2004, 114:1372-1378.
109. Gribben J.G., Freeman G.J., Boussiotis V.A., Rennert P., Jellis C.L., Greenfield E., et al. CTLA4 mediates antigen-specific apoptosis of human T cells. Proc Natl Acad Sci U S A 1995, 92:811-815.
110. Waterhouse P., Penninger J.M., Timms E., Wakeham A., Shahinian A., Lee K.P., et al. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 1995, 270:985-988.
111. Chen Z., Stockton J., Mathis D., Benoist C. Modeling CTLA4-linked autoimmunity with RNA interference in mice. Proc Natl Acad Sci U S A 2006, 103:16400-16405.
112. O'Mahony C., Scully P., O'Mahony D., Murphy S., O'Brien F., Lyons A., et al. Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kB activation. PLoS Pathog 2008, 4.
113. O'Mahony L., McCarthy J., Kelly P., Hurley G., Luo F., Chen K., et al. Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005, 128:541-551.
114. Whorwell P.J., Altringer L., Morel J., Bond Y., Charbonneau D., O'Mahony L., et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 2006, 101:1581-1590.
115. Schwartz R.H. Natural regulatory T cells and self tolerance. Nat Immunol 2005, 6:327-330.
116. Issazadeh-Navikas S., Teimer R., Bokermann R. Influence of dietary components on regulatory T cells. Mol Med 2012, 18:95-110.
117. Feleszko W., Jaworska J., Rha R.D., Steinhausen S., Avagyan A., Jaudszus A., et al. Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin Exp Allergy 2007, 37:498-505.
118. Kim J.Y., Choi Y.O., Ji G.E. Effect of oral probiotics (Bifidobacterium lactis AD011 and Lactobacillus acidophilus AD031) administration on ovalbumin-induced food allergy mouse model. J Microbiol Biotechnol 2008, 18:1393-1400.
119. Kim J.Y., Park M.S., Ji G.E. Probiotic modulation of dendritic cells co-cultured with intestinal epithelial cells. World J Gastroenterol 2012, 18:1308-1318.
120. Lavasani S., Dzhambazov B., Nouri M., Fåk F., Buske S., Molin G., et al. A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS One 2010, 5.
121. Kim H.J., Kim Y.J., Lee S.H., Yu J., Jeong S.K., Hong S.J. Effects of Lactobacillus rhamnosus on allergic March model by suppressing Th2, Th17, and TSLP responses via CD4(+)CD25(+)FoxP3(+) tregs. Clin Immunol 2014, 153:178-186.
122. Atarashi K., Tanoue T., Oshima K., Suda W., Nagano Y., Nishikawa H., et al. Treg induction by a rationally selected mixture of clostridia strains from the human microbiota. Nature 2013, 500:232-236.
123. Hacini-Rachinel F., Gheit H., Le Luduec J.B., Dif F., Nancey S., Kaiserlian D. Oral probiotic control skin inflammation by acting on both effector and regulatory T cells. PLoS One 2009, 4.
124. So J.S., Lee C.G., Kwon H.K., Yi H.J., Chae C.S., Park J.A., et al. Lactobacillus casei potentiates induction of oral tolerance in experimental arthritis. Mol Immunol 2008, 46:172-180.
125. Karimi K., Inman M.D., Bienenstock J., Forsythe P. Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. Am J Respir Crit Care Med 2009, 179:186-193.
126. Roselli M., Finamore A., Nuccitelli S., Carnevali P., Brigidi P., Vitali B., et al. Prevention of TNBS-induced colitis by different lactobacillus and Bifidobacterium strains is associated with an expansion of gamma-deltaT and regulatory T cells of intestinal intraepithelial lymphocytes. Inflamm Bowel Dis 2009, 15:1526-1536.
127. Pronio A., Montesani C., Butteroni C., Vecchione S., Mumolo G., Vestri A., et al. Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells. Inflamm Bowel Dis 2008, 14:662-668.
128. + T cell-mediated skin inflammation. Eur J Immunol 2004, 34:2520-2528.
129. Weise C., Zhu Y., Ernst D., Kühl A.A., Worm M. Oral administration of Escherichia coli nissle 1917 prevents allergen-induced dermatitis in mice. Exp Dermatol 2011, 20:805-809.
130. Meka R.R., Venkatesha S.H., Dudics S., Acharya B., Moudgil K.D. IL-27-induced modulation of autoimmunity and its therapeutic potential. Autoimmun Rev 2015, 14:1131-1141.
131. Hall A.O., Beiting D.P., Tato C., John B., Oldenhove G., Lombana C.G., et al. The cytokines interleukin 27 and interferon-gamma promote distinct treg cell populations required to limit infection-induced pathology. Immunity 2012, 37:511-523.
132. Yoshida H., Hunter C.A. The immunobiology of interleukin-27. Annu Rev Immunol 2015, 33:417-443.
133. Moon S.J., Park J.S., Heo Y.J., Kang C.M., Kim E.K., Lim M.A., et al. In vivo action of IL-27: reciprocal regulation of Th17 and treg cells in collagen-induced arthritis. Exp Mol Med 2013, 45.
134. Do J.S., Visperas A., Sanogo Y.O., Bechtel J.J., Dvorina N., Kim S., et al. An IL-27/Lag3 axis enhances Foxp3 regulatory T cell-suppressive function and therapeutic efficacy. Mucosal Immunol 2015, 10.1038/mi.2015.45.
135. Jeon S.G., Kayama H., Ueda Y., Takahashi T., Asahara T., Tsuji H., et al. Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon. PLoS Pathog 2012, 8.
136. Sung C.Y., Lee N.P., El-Nezami H. Regulation of T helper 17 by bacteria: an approach for the treatment of hepatocellular carcinoma. Int J Hepatol 2012, 2012:439024.
137. Chen C.C., Chiu C.H., Lin T.Y., Shi H.N., Walker W.A. Effect of probiotics Lactobacillus acidophilus on citrobacter rodentium colitis: the role of dendritic cells. Pediatr Res 2009, 65:169-175.
138. Jan R.L., Yeh K.C., Hsieh M.H., Lin Y.L., Kao H.F., Li P.H., et al. Lactobacillus gasseri suppresses Th17 pro-inflammatory response and attenuates allergen-induced airway inflammation in a mouse model of allergic asthma. Br J Nutr 2012, 108:130-139.
139. Veckman V., Miettinen M., Pirhonen J., Sirén J., Matikainen S., Julkunen I. Streptococcus pyogenes and Lactobacillus rhamnosus differentially induce maturation and production of Th1-type cytokines and chemokines in human monocyte-derived dendritic cells. J Leukoc Biol 2004, 75:764-771.
140. López P., González-Rodríguez I., Gueimonde M., Margolles A., Suárez A. Immune response to Bifidobacterium bifidum strains support treg/Th17 plasticity. PLoS One 2011, 6.
141. Noack M., Miosse P. Th17 and regulatory T cell balance in autoimmune and inflammatory diseases. Autoimmun Rev 2014, 13:668-677.
142. Miettinen M., Lehtonen A., Julkunen I., Matikainen S. Lactobacilli and streptococci activate NF-kB and STAT signaling pathways in human macrophages. J Immunol 2000, 164:3733-3740.
143. Laurence A., Tato C.M., Davidson T.S., Kanno Y., Chen Z., Yao Z., et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007, 26:371-381.
144. Wheeler J.G., Bogle M.L., Shema S.J., Shirrell M.A., Stine K.C., Pittler A.J., et al. Impact of dietary yogurt on immune function. Am J Med Sci 1997, 313:120-123.
145. Mokrozub V.V., Babenko L.P., Sokolvyak O.Y., Lazarenko L.M., Spivak M.Y. Effect of lactobacilli probiotic strains on IFN-γ, IL-2 and TNF-α- production in the peripheral blood cells culture of clinically healthy donors. EPMA J 2014, 5:A135.
146. Perdigon G., Maldonado Galdeano C., Valdez J.C., Medici M. Interaction of lactic acid bacteria with the gut immune system. Eur J Clin Nutr 2002, 56:S21-S26.
147. Marschan E., Kuitunen M., Kukkonen K., Poussa T., Sarnesto A., Haahtela T., et al. Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. Clin Exp Allergy 2008, 38:611-618.
148. Gareau M.G., Sherman P.M., Walker W.A. Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol 2010, 7:503-514.
149. Rachmilewitz D., Katakura K., Karmeli F., Hayashi T., Reinus C., Rudensky B., et al. Toll-like receptor 9 signaling mediates anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004, 126:520-528.
150. Hoarau C., Lagaraine C., Martin L., Velge-Roussel F., Lebranchu Y. Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a toll-like receptor 2 pathway. J Allergy Clin Immunol 2006, 117:696-702.
151. Forsythe P., Inman M.D., Bienenstock J. Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice. Am J Respir Crit Care Med 2007, 175:561-569.
152. Baban B., Hansen A.M., Chandler P.R., Manlapat A., Bingaman A., Kahler D.J., et al. Minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type-I IFN signaling following B7 ligation. Int Immunol 2005, 17:909-919.
153. Aumeunier A., Grela F., Ramadan A., Pham Van L., Bardel E., Gomez Alcala A., et al. Systemic toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice. PLoS One 2010, 5.
154. Round J.L., Lee S.M., Li J., Tran G., Jabri B., Chatila T.A., et al. The toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 2011, 332:974-977.
155. Mazmanian S.K., Round J.L., Kasper D.L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008, 453:620-625.
156. Mazmanian S.K., Liu C.H., Tzianabos A.O., Kasper D.L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005, 122:107-118.
157. Zeng H., Chi H. Metabolic control of regulatory T cell development and function. Trends Immunol 2015, 36:3-12.
158. Goldsmith J.R., Sartor R.B. The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. J Gastroenterol 2014, 49:785-798.
159. Hamer H.M., Jonkers D., Venema K., Vanhoutvin S., Troost F.J., Brummer R.J. The role of butyrate on colonic function. Aliment Pharmacol Ther 2008, 27:104-119.
160. Frank D.N., St Amand A.L., Feldman R.A., Boedeker E.C., Harpaz N., Pace N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007, 104:13780-13785.
161. Wang T., Cai G., Qiu Y., Fei N., Zhang M., Pang X., et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J 2012, 6:320-329.
162. Smith P.M., Howitt M.R., Panikov N., Michaud M., Gallini C.A., Bohlooly-Y M., et al. The microbial metabolites, short-chain fatty acids, regulate colonic treg cell homeostasis. Science 2013, 341:569-573.
163. Blad C.C., Tang C., Offermanns S. G protein-coupled receptors for energy metabolites as new therapeutic targets. Nat Rev Drug Discov 2012, 11:603-619.
164. Ganapathy V., Thangaraju M., Prasad P.D., Martin P.M., Singh N. Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host. Curr Opin Pharmacol 2013, 13:869-874.
165. Taggart A.K., Kero J., Gan X., Cai T.Q., Cheng K., Ippolito M., et al. (D)-beta-hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J Biol Chem 2005, 280:26649-26652.
166. Thangaraju M., Cresci G.A., Liu K., Ananth S., Gnanaprakasam J.P., Browning D.D., et al. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res 2009, 69:2826-2832.
167. Cresci G.A., Thangaraju M., Mellinger J.D., Liu K., Ganapathy V. Colonic gene expression in conventional and germ-free mice with a focus on the butyrate receptor GPR109A and the butyrate transporter SLC5A8. J Gastrointest Surg 2010, 14:449-461.
168. Lukasova M., Malaval C., Gille A., Kero J., Offermanns S. Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells. J Clin Invest 2011, 121:1163-1173.
169. Hegyi J., Schwartz R.A., Hegyi V. Pellagra: dermatitis, dementia, and diarrhea. Int J Dermatol 2004, 43:1-5.
170. Singh N., Gurav A., Sivaprakasam S., Brady E., Padia R., Shi H., et al. Activation of GPR109A, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 2014, 40:128-139.
171. Le Poul E., Loison C., Struyf S., Springael J.Y., Lannoy V., Decobecq M.E., et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 2003, 278:25481-25489.
172. Kim S., Kim Y.M., Kwak Y.S. A novel therapeutic target, GPR43; where it stands in drug discovery. Arch Pharm Res 2012, 35:1505-1509.
173. Cousens L.S., Gallwitz D., Alberts B.M. Different accessibilities in chromatin to histone acetylase. J Biol Chem 1979, 254:1716-1723.
174. Glozak M.A., Sengupta N., Zhang X., Seto E. Acetylation and deacetylation of non-histone proteins. Gene 2005, 363:15-23.
175. Li B., Samanta A., Song X., Iacono K.T., Bembas K., Tao R., et al. FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression. Proc Natl Acad Sci U S A 2007, 104:4571-4576.
176. Wang L., Tao R., Hancock W.W. Using histone deacetylase inhibitors to enhance Foxp3(+) regulatory T-cell function and induce allograft tolerance. Immunol Cell Biol 2009, 87:195-202.
177. Tao R., de Zoeten E.F., Ozkaynak E., Chen C., Wang L., Porrett P.M., et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med 2007, 13:1299-1307.
178. Arpaia N., Campbell C., Fan X., Dikiy S., van der Veeken J., deRoos P., et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013, 504:451-455.
179. Furusawa Y., Obata Y., Fukuda S., Endo T.A., Nakato G., Takahashi D., et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013, 504:446-450.
180. Chang P.V., Hao L., Offermanns S., Medzhitov R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci U S A 2014, 111:2247-2252.
181. Willemsen L.E., Koetsier M.A., van Deventer S.J., van Tol E.A. Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts. Gut 2003, 52:1442-1447.
182. Nitta M., Hirata I., Toshina K., Murano M., Maemura K., Hamamoto N., et al. Expression of the EP4 prostaglandin E2 receptor subtype with rat dextran sodium sulphate colitis: colitis suppression by a selective agonist, ONO-AE1-329. Scand J Immunol 2002, 56:66-75.
183. Kalinski P. Regulation of immune responses by prostaglandin E2. J Immunol 2012, 188:21-28.
184. Perez R., Stevenson F., Johnson J., Morgan M., Erickson K., Hubbard N.E., et al. Sodium butyrate upregulates kupffer cell PGE2 production and modulates immune function. J Surg Res 1998, 78:1-6.
185. + T regulatory cell activities in lung cancer. Cancer Res 2005, 65:5211-5220.
186. Bergmann C., Strauss L., Zeidler R., Lang S., Whiteside T.L. Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma. Cancer Res 2007, 67:8865-8873.
187. Soontrapa K., Honda T., Sakata D., Yao C., Hirata T., Hori S., et al. Prostaglandin E2- prostaglandin E receptor subtype 4 (EP4) signaling mediates UV irradiation induced systemic immunosuppression. Proc Natl Acad Sci U S A 2011, 108:6668-6673.
188. + adaptive regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E2-dependent mechanism. J Immunol 2006, 177:246-254.
189. Phipps R.P., Stein S.H., Roper R.L. A new view of prostaglandin E regulation of the immune response. Immunol Today 1991, 12:349-352.
190. Muthuswamy R., Urban J., Lee J.J., Reinhart T.A., Bartlett D., Kalinski P. Ability of mature dendritic cells to interact with regulatory T cells is imprinted during maturation. Cancer Res 2008, 68:5972-5978.
191. + T cells. J Immunol 2005, 175:1483-1490.
192. Whiteside T.L., Jackson E.K. Adenosine and prostaglandin E2 production by human inducible regulatoryT cells in health and disease. Front Immunol 2013, 4:212.
193. Su Y., Huang X., Raskovalova T., Zacharia L., Lokshin A., Jackson E., et al. Cooperation of adenosine and prostaglandin E2 (PGE2) in amplification of cAMP-PKA signaling and immunosuppression. Cancer Immunol Immunother 2008, 57:1611-1623.
194. + regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A 2010, 107:12204-12209.
195. Ochoa-Repáraz J., Mielcarz D.W., Ditrio L.E., Burroughs A.R., Foureau D.M., Haque-Begum S., et al. Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J Immunol 2009, 183:6041-6050.
196. Ochoa-Repáraz J., Mielcarz D.W., Wang Y., Begum-Haque S., Dasgupta S., Kasper D.L., et al. A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunol 2010, 3:487-495.
197. Prioult G., Fliss I., Pecquet S. Effect of probiotic bacteria on induction and maintenance of oral tolerance to β-lactoglobulin in gnotobiotic mice. Clin Diagn Lab Immunol 2003, 10:787-792.
198. Prioult G., Pecquet S., Fliss I. Stimulation of interleukin-10 production by acidic beta lactoglobulin-derived peptides hydrolyzed with lactobacillus paracasei NCC2461 peptidases. Clin Diagn Lab Immunol 2004, 11:266-271.